Cvs Health (CVS) Receivables - Other (2017 - 2025)
Cvs Health (CVS) has disclosed Receivables - Other for 9 consecutive years, with $7.9 billion as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Other fell 0.84% year-over-year to $7.9 billion, compared with a TTM value of $7.9 billion through Dec 2025, down 0.84%, and an annual FY2025 reading of $7.9 billion, down 0.84% over the prior year.
- Receivables - Other was $7.9 billion for Q4 2025 at Cvs Health, down from $10.0 billion in the prior quarter.
- Across five years, Receivables - Other topped out at $11.9 billion in Q4 2023 and bottomed at $2.5 billion in Q2 2022.
- Average Receivables - Other over 5 years is $7.3 billion, with a median of $8.0 billion recorded in 2022.
- The sharpest move saw Receivables - Other plummeted 68.73% in 2022, then skyrocketed 296.69% in 2023.
- Year by year, Receivables - Other stood at $3.4 billion in 2021, then grew by 1.77% to $3.4 billion in 2022, then skyrocketed by 245.26% to $11.9 billion in 2023, then crashed by 33.1% to $8.0 billion in 2024, then decreased by 0.84% to $7.9 billion in 2025.
- Business Quant data shows Receivables - Other for CVS at $7.9 billion in Q4 2025, $10.0 billion in Q3 2025, and $10.5 billion in Q2 2025.